Profilo
Georg V.
Beiske is the founder of Tribune Therapeutics AB, founded in 2020, where the title held is Chief Executive Officer.
The current job is Venture Partner at HealthCap AB, starting in 2021.
Former job includes Development Manager at Bayer AS.
Education includes a graduate degree from the University of Oslo, conferred in 2013.
Posizioni attive di Georg Beiske
| Società | Posizione | Inizio |
|---|---|---|
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Investitore di Private Equity | 01/06/2021 |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as preclinical biopharmaceutical company that develops medicines to treat patients with fibrotic diseases | Amministratore Delegato | 01/01/2020 |
Precedenti posizioni note di Georg Beiske
| Società | Posizione | Fine |
|---|---|---|
Bayer AS
Bayer AS Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Corporate Officer/Principal | - |
Formazione di Georg Beiske
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Finance |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer AS
Bayer AS Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as preclinical biopharmaceutical company that develops medicines to treat patients with fibrotic diseases | Commercial Services |
















